Course Overview

The MSc in Cancer Therapies is unique in the UK. It's a multifaceted course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology. You'll also gain an understanding of the practical, ethical and economic implications of personalised cancer therapy. The degree is for graduates seeking experience in various topics essential to learning and developing cancer therapies.

You'll be taught at the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK. The Institute has significant facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit – the only one in the UK. You'll therefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas.

The course has been developed to produce world-class graduates with the skills to contribute to the global drive to advance cancer treatment through research, teaching, industry and public sector employment.

General Eligibility

Academic requirements/experience

Minimum second-class (2.2) Honours degree or international equivalent in a science or health-related subject

Students with alternative entry standards or professional experience may also be considered and are usually admitted in the first instance to the Diploma course. Upon satisfactory completion of all Semester 1 assessments, these students will be offered the chance to transfer to the MSc programme.

Part Time Work Details

20 hours of work permit weekly for international students.

Language Requirement

• IELTS 6.0 (with no component below 5.5).